MiR-29a suppresses cell proliferation by targeting SIRT1 in hepatocellular carcinoma

Area of Science:

• Molecular biology
• Oncology
• Gene regulation

Background:

• MicroRNAs (miRNAs) regulate gene expression by targeting mRNA degradation or translational suppression.
• Emerging evidence suggests miR-29a functions as a tumor suppressor in hepatocellular carcinoma (HCC).
• The precise role and mechanisms of miR-29a in HCC progression require further elucidation.

Purpose of the Study:

• To investigate the expression levels of miR-29a in HCC tissues.
• To explore the functional role of miR-29a in HCC cell proliferation, cell cycle, and survival.
• To identify the downstream target of miR-29a and its regulatory mechanism in HCC.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) for miR-29a expression analysis in HCC and adjacent normal tissues.
• Cell proliferation assays (CCK8, colony formation) and flow cytometry to assess cell cycle.
• Bioinformatics, dual-luciferase reporter assays, qRT-PCR, and Western blot to validate SIRT1 as a direct target of miR-29a.

Main Results:

• miR-29a expression was significantly downregulated in HCC tissues and correlated with tumor size and vascular invasion.
• Lower miR-29a levels predicted poor disease-free survival and overall survival in HCC patients.
• Overexpression of miR-29a suppressed HCC cell proliferation, colony formation, and induced cell cycle arrest by modulating CyclinD1, CDK4, and P21 expression.
• miR-29a directly targets SIRT1 mRNA's 3'-UTR, inhibiting its protein expression; SIRT1 overexpression rescued miR-29a's inhibitory effects.

Conclusions:

• miR-29a acts as a tumor suppressor in HCC by targeting SIRT1 and regulating cell cycle progression.
• Downregulation of miR-29a is associated with aggressive tumor characteristics and poor prognosis in HCC.
• miR-29a holds potential as a therapeutic target for hepatocellular carcinoma treatment.